Martínez-García, Maria; Velasco, Guillermo; Pineda, Estela; Gil-Gil, Miguel J.; Alameda Quitllet, Francisco; Capellades Font, Jaume; Martín-Soberón, Mari Cruz; López-Valero, Israel; Tovar Ambel, Elena; Foro Arnalot, Palmira; Taus García, Álvaro; Arumí Uría, Montserrat; Hernández-Laín, Aurelio; Sepúlveda-Sánchez, Juan Manuel
(MDPI, 2022)
Background: MET-signaling and midkine (ALK ligand) promote glioma cell maintenance and resistance against anticancer therapies. ALK and c-MET inhibition with crizotinib have a preclinical therapeutic rationale to be tested ...